A rare bladder cancer - Small cell carcinoma: Review and update

Orphanet Journal of Rare Diseases

Volumn 6, Issue 1, 2011, Pages

  Ismaili, Nabil ^a  

^a Centre Régional d'Oncologie   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; CD44V6 ANTIGEN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; ERLOTINIB; ETOPOSIDE; EVEROLIMUS; GEFITINIB; IFOSFAMIDE; IMATINIB; IRINOTECAN; LAPATINIB; METHOTREXATE; NAVELBINE; NEURON SPECIFIC ENOLASE; PACLITAXEL; PAZOPANIB; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SORAFENIB; SUNITINIB; THYROID TRANSCRIPTION FACTOR 1; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ADJUVANT CHEMOTHERAPY; BLADDER CANCER; BLADDER SMALL CELL CARCINOMA; BONE METASTASIS; BRAIN METASTASIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CYSTECTOMY; DYSURIA; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SMALL CELL CARCINOMA; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; WEIGHT REDUCTION; ADJUVANT THERAPY; ADULT; AGED; BLADDER TUMOR; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; URINARY BLADDER NEOPLASMS;

EID: 81055124240     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-6-75     Document Type: Review

References (45)

1. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cramer SF, Aikawa M, Cebelin M, Cancer 1981 47 4 724 30 10.1002/1097-0142(19810215)47:4<724::AID-CNCR2820470417>3.0.CO;2-2 6261916 (Pubitemid 11135870)
2. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphologic, immunohistochemical and ultrastructural study of 18 cases. Blomjous CEM, Vos W, De Voogt HJ, van der Valk P, Meijer CJLM, Cancer 1989 64 6 1347 57 10.1002/1097-0142(19890915)64:6<1347::AID-CNCR2820640629>3.0.CO;2-Q 2548704 (Pubitemid 19217117)
3. Primary small cell carcinoma of the bladder: a report of 25 cases. Holmang S, Borghede G, Johansson SL, J Urol 1995 153 6 1820 2 10.1016/S0022-5347(01)67320-8 7752326
4. Small cell carcinoma of the bladder: Long term outcome with integrated chemoradiation. Lohrisch C, Murray N, Pickles T, Sullivan L, Cancer 1999 86 11 2346 52 10.1002/(SICI)1097-0142(19991201)86:11<2346::AID-CNCR24>3.0.CO;2-5 10590377 (Pubitemid 30010377)
5. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Choong NW, Quevedo JF, Kaur JS, Cancer 2005 103 6 1172 8 10.1002/cncr.20903 15700264 (Pubitemid 40328087)
6. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern California experience. Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J, Groshen S, Stein JP, Skinner DG, J Urol 2005 174 1 93 6 10.1097/01.ju.0000162085.20043.1f 15947585 (Pubitemid 40825681)
7. Small cell cancer of the bladder: The Leon-Berard cancer centre experience. Ismaili N, Elkarak F, Heudel PE, Flechon A, Droz JP, Indian J Urol 2008 24 494 497 10.4103/0970-1591.44255 19468504
8. Small cell carcinoma of the urinary bladder: A clinicopathologic analysis of 64 patients. Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, Kuzel TM, Papavero V, Tretiakova M, Nigro K, Koch MO, Eble JN, Cancer 2004 101 5 957 62 10.1002/cncr.20456 15329903 (Pubitemid 39100428)
9. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases. Abrahams NA, Moran C, Reyes AO, Siefker-Radtke A, Ayala AG, Histopathology 2005 46 1 57 63 10.1111/j.1365-2559.2004.01980.x 15656887 (Pubitemid 40193699)
10. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S, Urology 2005 65 2 295 9 10.1016/j.urology.2004.09.049 15708041 (Pubitemid 40248016)
11. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. Iczkowski KA, Shanks JH, Allsbrook WC, Lopez-Beltran A, Pantazis CG, Collins TR, Wetherington RW, Bostwick DG, Histopathology 1999 35 2 150 6 10.1046/j.1365-2559.1999.00715.x 10460660 (Pubitemid 29378515)
12. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL, Grossman HB, Swanson DA, Millikan RE, J Urol 2004 172 2 481 4 10.1097/01.ju.0000132413. 85866.fc 15247709 (Pubitemid 38900183)
13. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. Mukesh M, Cook N, Hollingdale AE, Ainsworth NL, Russell SG, BJU Int 2009 103 6 747 52 10.1111/j.1464-410X.2008.08241.x 19076139
14. Small-cell carcinoma of the urinary bladder: 10-year experience. Mangar SA, Logue JP, Shanks JH, Cooper RA, Cowan RA, Wylie JP, Clin Oncol (R Coll Radiol) 2004 16 8 523 7 10.1016/j.clon.2004.06.024 (Pubitemid 39517659)
15. Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. Bex A, de Vries R, Pos F, Kerst M, Horenblas S, World J Urol 2009 27 1 101 6 10.1007/s00345-008-0304-x 18607595
16. Small cell neuroendocrine carcinoma of the urinary bladder: a clinicopathologic study with emphasis on cytologic features. Ali SZ, Reuter VE, Zakowski MF, Cancer 1997 79 356 361 10.1002/(SICI)1097-0142(19970115)79: 2<356::AID-CNCR19>3.0.CO;2-# 9010109 (Pubitemid 27029900)
17. Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Oesterling JE, Brendler CB, Burgers JK, Marshall FF, Epstein JI, Cancer 1990 65 9 1928 36 10.1002/1097-0142(19900501) 65:9<1928::AID-CNCR2820650910>3.0.CO;2-X 2164873
18. Chromosomal imbalances in small cell carcinomas of the urinary bladder. Terracciano L, Richter J, Tornillo L, Beffa L, Diener PA, Maurer R, Gasser TC, Moch H, Mihatsch MJ, Sauter G, J Pathol 1999 189 2 230 5 10.1002/(SICI)1096- 9896(199910)189:2<230::AID-PATH407>3.0.CO;2-8 10547580 (Pubitemid 29448918)
19. Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. Christopher ME, Seftel AD, Sorenson K, Resnick MI, J Urol 1991 146 2 382 8 1713277
20. Cytology of small cell carcinoma of the urinary bladder. van Hoeven KH, Artymyshyn RL, Diagn Cytopathol 1996 14 4 292 7 10.1002/(SICI)1097-0339(199605) 14:4<292::AID-DC3>3.0.CO;2-I 8725127 (Pubitemid 26177675)
21. Small cell carcinoma of the urinary bladder with hypercalcemia. Reyes CV, Soneru I, Cancer 1985 56 10 2530 3 10.1002/1097-0142(19851115)56:10<2530:: AID-CNCR2820561035>3.0.CO;2-4 2994881 (Pubitemid 16202455)
22. Small cell carcinoma of the bladder. Sved P, Gomez P, Manoharan M, Civantos F, Soloway MS, BJU Int 2004 94 1 12 7 10.1111/j.1464-410X.2003.04893.x 15217423 (Pubitemid 38980301)
23. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Grignon DJ, Ro JY, Ayala AG, Shum DT, Ordá̃ez NG, Logothetis CJ, Johnson DE, Mackay B, Cancer 1992 69 2 527 36 10.1002/1097-0142(19920115)69:2<527::AID-CNCR2820690241>3.0.CO;2-7 1309435
24. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Lin H, Pan CX, Tretiakova M, Baldridge LA, Cheng L, Hum Pathol 2005 36 7 718 23 10.1016/j.humpath.2005.04. 007 16084939 (Pubitemid 41112025)
25. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, Folpe AL, Mod Pathol 2000 13 3 238 42 10.1038/modpathol.3880044 10757334 (Pubitemid 30207508)
26. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Wang X, Zhang S, MacLennan GT, Eble JN, Lopez-Beltran A, Yang XJ, Pan CX, Zhou H, Montironi R, Cheng L, Clin Cancer Res 2007 13 3 953 7 10.1158/1078-0432.CCR-06-2167 17289890 (Pubitemid 46340372)
27. c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Koch MO, Jones TD, Lin H, Nigro K, Papavero V, Tretiakova M, Cheng L, Mod Pathol 2005 18 3 320 3 10.1038/modpathol.3800318 15502806 (Pubitemid 40395348)
28. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations. Terada T, Pathol Int 2009 59 4 247 50 10.1111/j.1440-1827.2009.02358.x 19351368
29. From cytogenetics to cytogenomics of bladder cancers. Léonard C, Huret JL, Gfco; Groupe français, de cytogénétique oncologique, Bull Cancer 2002 89 2 166 73 11888856
30. Clinical review-small cell carcinoma of the bladder. Church DN, Bahl A, Cancer Treat Rev 2006 32 8 588 93 10.1016/j.ctrv.2006.07.013 17008012 (Pubitemid 44752562)
31. Small cell carcinoma of the urinary bladder: a case report and review of the literature. Ismaili N, Ghanem S, Mellas N, Afqir S, Taleb M, Amrani M, Gamra L, Errihani H, J Cancer Res Ther 2009 5 2 133 6 10.4103/0973-1482.52790 19542673
32. Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: Results in five cases. Bastús R, Caballero JM, González G, Borrat P, Casalots J, Gomez de Segura G, Martí LI, Ristol J, Cirera L, Eur Urol 1999 35 4 323 6 10.1159/000019870 10087396 (Pubitemid 29154839)
33. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. Siefker-Radtke AO, Kamat AM, Grossman HB, Williams DL, Qiao W, Thall PF, Dinney CP, Millikan RE, J Clin Oncol 2009 27 16 2592 7 10.1200/JCO.2008.19.0256 19414678
34. Outcome of recurrent and metastatic small cell carcinoma of the bladder. Ismaili N, Heudel PE, Elkarak F, Kaikani W, Bajard A, Ismaili M, Errihani H, Droz JP, Flechon A, BMC Urol 2009 9 4 10.1186/1471-2490-9-4 19500382
35. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. Mackey JR, Au HJ, Hugh J, Venner P, J Urol 1998 159 1624 1629 10.1097/00005392-199805000-00058 9554367 (Pubitemid 29117354)
36. The role of chemotherapy in the management of bladder cancer. Ismaili N, Amzerin M, Elmajjaoui S, Droz JP, Flechon A, Errihani H, Prog Urol 2011 21 6 369 82 21620296
37. Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer? Ismaili N, Elmajjaoui S, Bensouda Y, Belbaraka R, Abahssain H, Allam W, Fadoukhair Z, Mesmoudi M, Tanz R, Mahfoud T, Elomrani A, Khouchani M, Sbitti Y, Benjaafar N, Errihani H, Tahri A, Oncol Rev 2011 5 3 185 189 10.1007/s12156-011-0085-0
38. The impact of variant histology on the outcome of bladder cancer treated with curative intent. Black PC, Brown GA, Dinney CP, Urol Oncol 2009 27 1 3 7 10.1016/j.urolonc.2007.07.010 18367107
39. Small-cell carcinoma of the urinary bladder: diagnosis and management. Pan CX, Zhang H, Lara PN Jr, Cheng L, Expert Rev Anticancer Ther 2006 6 12 1707 13 10.1586/14737140.6.12.1707 17181484 (Pubitemid 46062305)
40. Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review. Bex A, Sonke GS, Pos FJ, Brandsma D, Kerst JM, Horenblas S, Ann Oncol 2010 21 11 2240 5 10.1093/annonc/mdq225 20427346
41. Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: A case series and review of the literature. June RR, Dougherty DW, Reese CT, Harpster LE, Hoffman SL, Drabick JJ, Urol Oncol 2010
42. Treatment options for small cell lung cancer-do we have more choice? Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O'Brien ME, Br J Cancer 2010 102 4 629 38 10.1038/sj.bjc.6605527 20104223
43. Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis. Ismaili N, Arifi S, Flechon A, El Mesbahi O, Blay JY, Droz JP, Errihani H, Bull Cancer 2009 96 6 30 44 19457759
44. Small cell carcinoma of the urinary bladder. Pant-Purohit M, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L, Histol Histopathol 2010 25 2 217 21 20017108
45. Small cell carcinoma of the urinary bladder - histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Wang X, MacLennan GT, Lopez-Beltran A, Cheng L, Appl Immunohistochem Mol Morphol 2007 15 1 8 18 10.1097/01.pai.0000213106.12731.d7 17536302 (Pubitemid 46673311)